Post My Press Release

Free Press Release Distribution

Author: ankushraoaniket@yandex.com (Page 1 of 17)

Hepatic Encephalopathy Market Growth and Sales Forecast 2017 – 2025

Hepatic encephalopathy is a disorder detected in patients suffering from cirrhosis. It is a syndrome that occurs in patients with liver dysfunction and is defined as a spectrum of neuropsychiatric abnormalities, after exclusion of brain disease. Hepatic encephalopathy is categorized by intellectual impairment, a depressed level of consciousness, and personality changes. The symptoms of hepatic encephalopathy includes changes in sleeping patterns, disorientation, slurred speech and agitation, drowsiness or confusion, and excitement. The influencing factors for hepatic encephalopathy includes constipation (due to increased nitrogen load), increased protein intake with azotemia, drugs, and hypoxia, gastrointestinal bleeding, and renal dysfunction.

Read Report Overview:

https://www.transparencymarketresearch.com/hepatic-encephalopathy-market.html

The hepatic encephalopathy market can be segmented by types, treatment, and geography. Based on types, the market can be categorized into Type A, Type B, and Type C. Type A hepatic encephalopathy is related to acute liver failure that leads to rapid deterioration of the liver in patients suffering from pre-existing liver disorders. Acute liver failure that causes complications such as elevated pressure and excessive bleeding in the brain is known as fulminant hepatic failure that requires emergency hospitalization. Type B hepatic encephalopathy is related to portal-systemic bypass deprived of liver disorder. Type B hepatic encephalopathy arises when blood streams around the liver and hence the liver cannot remove or control elements in the blood. Type B generally arises as a result of hereditary abnormalities and as a result of invasive procedures or trauma. Type C hepatic encephalopathy is related to cirrhosis. Cirrhosis is the last phase of chronic liver disease when damaging fibrosis matures. As a result, problems of cirrhosis is reflected in bruising and bleeding easily, jaundice (a yellow discoloration of the skin and whites of the eyes), painful swelling of the legs (edema), fluid build-up in the abdomen (ascites), and portal hypertension (a rise in the blood pressure within a system of veins called the portal venous system).

Furthermore, on the basis of treatments, the hepatic encephalopathy market is categorized into lactulose, antibiotics, probiotics, branched-chain amino acids, and liver transplantation. Lactulose is a synthetic form of sugar that is not absorbed into the body. Lactulose creates an aggressive environment for the bad microbes in the intestine, thus reducing ammonia production in the intestine. Antibiotics such as Rifaximin and Metronidazole may be used to slow down the development of bacteria in the intestine, including bacteria which produce ammonia. Rifaximin is slowly absorbed into the body that helps it to deliberate in the intestines, where it can decrease the growth of unfavorable bacteria. Probiotics or favorable microbes can change the balance of microbes in the intestines, increasing the proportion of favorable bacteria. This can result in reduced levels of ammonia production and other toxic substances. Branched-chain amino acids Valine, Leucine, and Isoleucine can help uphold muscle mass and increase ammonia clearance. Liver transplantation is the final treatment for hepatic encephalopathy wherein the damaged liver is replaced with a healthy donor’s liver. Patients who receive a liver transplant recover their brain function. However, it is important to control and stop incidents of over hepatic encephalopathy, because several incidents of over hepatic encephalopathy can possibly lead to enduring and therefore irreversible brain damage.

On the basis of geography, the global hepatic encephalopathy market is segmented into five key regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the dominant market followed by Europe. Rising patient awareness about different treatment options and increasing demand for treatment is expected to influence the market in North America. The hepatic encephalopathy market is growing due to increasing population, better treatment options, and rising demand for rapid diagnosis globally. Presently, the U.S. is the main country contributing to the global hepatic encephalopathy market, where the financial burden of hepatic encephalopathy is significant. Followed by ascites, hepatic encephalopathy is the second most common cause for hospitalization of cirrhotic patients in the U.S. In addition, the market for global hepatic encephalopathy is expected to expand at a healthy rate in the next few years due to lack of treatment options.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31535

The major players operating in the global hepatic encephalopathy market are Alfa Wassermann S.p.A, Cosmo Pharmaceuticals S.p.A, KannaLife Sciences, Inc., Ocera Therapeutics, Inc., Rebiotix Inc., Spherium Biomed S.L., and Umecrine Cognition AB among others. Increasing competition among key players to develop new therapies for hepatic encephalopathy will drive the market globally.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Macular Edema Market Growth and Sales Forecast 2017 – 2025

Macula is the oval yellowish area surrounding the focal point of the retina in the eye. Macular edema is the state when liquid and protein begin collecting under the macula leading to swelling in the eye. Focal vision of the eye gets mutilated because of this swelling. The retina is the light-delicate tissue at the back of the eye and the macula is the piece of the retina in charge of sharp, straight-ahead vision. Diabetic retinopathy is the main reason for macular edema which happens because of diabetes. Macular edema can likewise be analyzed in quiet after eye surgery for waterfall, glaucoma, or retinal illness. Ailments which harm the vein in the retina can cause macular edema. Wavy or foggy vision to observable vision misfortune are essential side effects of macular edema. On the off chance that one eye influenced, there is half likelihood that other eye can likewise be influenced. Treatment for macular edema depends on why it is caused, and may take several months to resolve. During this time, it is important to follow the treatment regimen thoroughly.

Read Report Overview:

https://www.transparencymarketresearch.com/macular-edema-market.html

On the basis of type, the macular edema market is divided into two types: cystoids macular edema (CME) and diabetic macular edema (DME). On the basis of treatment, the market is divided into drug therapy and laser treatment. The drug therapy segment is growing at a faster rate than the laser treatment segment as many ophthalmologists prefer drug therapy as the first line therapy to cure the disease. Moreover, laser treatment is costly as compared to drug therapy. On the basis of tests, the macular edema treatment market is segmented into visual acuity test; dilated exam test; and tonometry test. The adjustment in way of life have the expanded rate of diabetic patients is significant driving variables of macular therapeutics advertise comprehensively. Several eye disorders are caused due to changing climatic conditions. Growing aging population has led to increased occurrence of eye infections. Disappointment of eye surgery waterfall, glaucoma, or retinal ailment can likewise rise the market of macular edema therapeutics around the world. Limited number of approved drugs and high cost involved in laser treatment hinders the growth of the market.

Geographically, North America and Europe are mature markets for diabetic macular edema because a large proportion of the population suffers from diabetes. Lucentis and Ozurdex drugs have major market share in the therapeutics market. The market in Asia Pacific is also growing at a fast pace and India is set to play a major role as in 2015 (according to International Diabetes Federation) around 69.1 million cases of diabetes was reported in India and half of them affected with visual impairments. The Middle East & Africa market for macular edema is driven by the developing predominance of vision impedance. Advancement in the field of medicine is a key factor driving the development of the market. Expanding geriatric population around the district along with an expansion in the discretionary cash flow of the general population are the other driving components.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32159

Some of the major companies operating in the macular edema market are Novartis, Roche, Allergan, Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer Inc. Bayer AG, and Bausch & Lomb Incorporated.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Culture Media Market is projected to be worth US$10.1 bn by 2025.

Transparency Market Research’s (TMR) new report on the global culture media market says the degree of competition in this market is high as companies are engaged in consistent breakthroughs and new discoveries for culture media. Nevertheless, the culture media market exhibits a fairly consolidated vendor landscape with top five companies holding close to 60% of the market in 2016.

Read Report Overview:

https://www.transparencymarketresearch.com/culture-media-market-media.html

“Leading companies in the culture media market are focused on mergers and acquisitions and strategic alliances with businesses with complementary strengths,” says a lead analyst at TMR. An excellent example is Thermo Fisher Scientific. In February 2014, the company acquired Life Technologies Corporation to strengthen its biosciences and bioprocessing businesses, thereby accelerating its drug discovery, development, and production capabilities.

High investments for innovative products is a key growth strategy that companies in the culture media market are focused on. A case in point is Thermo Fisher Scientific. The company invested a hefty sum of US$396 mn in 2013 to strengthen its research and development program.

The global culture media market stood at US$5,296.8 mn in 2016 and is projected to be worth US$10,138.6 mn by the end of 2025 expanding at a CAGR of 7.7% between 2017 and 2025.

North America Accounts for Significant Share in Global Market

In terms of media type, the culture media market is segmented into dehydrated culture media, chromogenic culture media, and prepared culture media. The segment of dehydrated culture media dominated the market in 2016 and is anticipated to retain its position until the end of 2025. Prepared culture media stood as the second-leading media type segment of the market in the same year. These segments offer benefits of faster because of which they are extensively used in diagnostic laboratories and research institutes.

In terms of end-user, hospitals dominated holding 43.5% of the culture media market in 2016. This was followed by the segment of academic and research institutes and is expected to maintain its second-leading position over the forecast period between 2017 and 2025. On the other hand, the diagnostic centers segment is expected to display a declined market share between 2016 and 2025.

In terms of geography, the global culture media market is divided into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America, among these accounts for the leading contribution to the global culture media market. Between 2016 and 2025, the share of this region is expected to increase from 39.3% to 43%. Advances in medical technology with a corresponding increase in application of culture media are key factors for the dominance of North America in the global market. The U.S. accounts for the major share of North America culture media market.

Europe is the second-leading regional segment in the culture media market. The significant position of this region is mainly due to substantial investments from top players for research and development pursuits for disease diagnosis.

Mounting Research and Development for Customized Line of Treatment for Diseases Boosts Demand

Increasing demand for antibiotics is the primary factor propelling the culture media market. The increasing resistance of bacteria to antibiotics is necessitating the development of new antibiotics for treating disease indication. Research and development initiatives for newer pharmaceutical products for application in disease diagnosis is further benefitting the growth of this market.

Request Sample of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26273

On the downside, high cost associated for the preparation of various types of culture media and stringent process controls are challenging the market’s growth.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Erdosteine Market Research Key Players, Industry Overview and Forecasts to 2024

Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and enhances elimination. Erdosteine shows inhibitory activity against the effects of free radicals produced by cigarette smoke. Pharmacokinetically, it acts by absorption, distribution, metabolism, and excretion. The elimination half-life of Erdosteine is about 1.46 hr. Adverse events of Erdosteine are quite low, and generally mild. It has been clinically proven that Erdosteine has good gastric tolerability after oral administration, and does not cause reflux phenomena like other thiols derivatives. Erdosteine has no direct effect on gastric mucus.

Read Report Overview:

https://www.transparencymarketresearch.com/erdosteine-market.html

Increasing prevalence of respiratory diseases, rising geriatric population, rapid population growth, and environmental pollution due to industrialization are expected to fuel the global erdosteine market. According to the WHO, chronic obstructive pulmonary disease (COPD) accounts for three million deaths globally each year and the number is expected to increase in the next few years. About 90% of chronic obstructive pulmonary disease (COPD) deaths occur in developing and underdeveloped countries. Rising research and development activities, increasing health care insurance coverage, and growing adoption for treatment options are the other factors driving the global erdosteine market. On the other hand, stringent regulations for product approval are likely to hamper the growth of the global erdosteine market. Erdosteine is used for rare diseases so maximum companies doing research and development which will increase the market competitiveness. Erdosteine is marketed in over 40 countries for the treatment of various respiratory diseases.

The erdosteine market has been segmented based on dosage form, age group, application, distribution channel, and region. In terms of dosage form, the market has been classified into capsules, dry suspension, dispersible tablets, and sachets. The capsule dosage form is highly used due to ease of use, availability in unit dosage form, and also easy in term of prescription scenario which will leads to less side effect. Based on age group, the erdosteine market has been segmented into adult and pediatric. In terms of application, the market has been classified into chronic obstructive pulmonary disease (COPD), acute bronchitis (AB), and chronic bronchitis (CB). Based on distribution channel, the erdosteine market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominated the erdosteine market due to rising geriatric population, early adoption of treatment procedures, and increasing prevalence of respiratory diseases. The geriatric population represents about 14.5% of the population of the U.S. According to the U.S. Department of Health and Human Service, the geriatric population will increase to 98 million by 2060, which is twice that in 2014. Europe is the second largest market for erdosteine attributed to increasing research and development activities and rising number of commercial licensing partnerships for erdosteine manufacturing. Asia Pacific is expected to grow at a higher rate driven by growing per capita expenditure, increasing health care insurance coverage, rapidly growing population, and rising per capita health care expenditure.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19166

Major players operating in the erdosteine market include Edmond Pharma S.R.L., Alitair Pharmaceuticals, Manus Aktteva Biopharma LLP, Enaltec, Reine Life Science, Taj Pharmaceuticals Ltd., Recipharm AB, Glenmark Pharmaceuticals Ltd., Sigma-Aldrich Co. LLC, Genome Pharmaceuticals (Pvt.) Ltd., and Milan Pharma.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Stem Cell Assay Market Research and Analyzed Report for 2016 – 2024

Regenerative medicine has emerged as new paradigm in human health. It has the potential to resolve unmet medical needs. Rapid growth in the interdisciplinary field of regenerative medicine is altering the health care domain by converting fundamental science into a variety of regenerative technologies. Stem cell is an undifferentiated mass of cell that has the ability to divide indefinite times. It can be further differentiated into specialized cells such as blood cells, skin cells, neurons, heart cells, chondrocytes, and osteocytes under specific conditions. Unspecialized nature, self-renewal capability, and dedifferentiation are the unique features of stem cells. Thus, these cells are useful in different applications in pharmaceutical research and medical fields. Stem cell research has grown significantly since 1978, when stem cells were discovered in human cord blood. Incidence of cancer is increasing across the globe due to the rise in aging population and changing lifestyle habits. This, in turn, is boosting the demand for anticancer drugs and therapies. According to the Centers for Disease Control and Prevention, 14.1 million new cancer cases were diagnosed around the globe in 2012 and around 19.3 million new cancer cases are expected to be diagnosed each year by 2025. Rise in incidences of chronic diseases is boosting the demand for research, making stem cells a highly preferred system for drug discovery due to its self-renewal capability and unspecialized nature.

Read Report Overview:

https://www.transparencymarketresearch.com/stem-cell-assay-market.html

Over the last decade, the application of cell-based assays has increased at a rapid pace among research institutes and pharmaceutical industries. This was primarily ascribed to the ethical issues associated with the use of animals for clinical trials. Furthermore, rise in approvals of clinical trials for stem cells based therapy, increase in funds from government organizations, and technological advancements are some of the factors driving the stem cell assay market. But, human embryonic stem cells, which are derived from inner cell mass of blastocyst are currently high on the political issues ethical concerns in many countries hampering the growth of the market. Additionally, lack of required infrastructure in developing countries and high cost associated with products are some of the factors restraining the stem cell assay market. Evolution of new therapies and low regulatory frameworks in emerging regions are expected to provide opportunities for market growth during the forecast period.

The global stem cell assay market has been segmented based on product, assay type, application, end-user, and region. In terms of product, the market for stem cell assay has been divided into human embryonic stem cell kits and adult stem cell kits. The adult stem cell kits segment is further divided into induced pluripotent stem cells kits, hematopoietic stem cell kits, mesenchymal stem cell kits, umbilical cord stem cell kits, and others. The adult stem cell kits segment is expected to account for the prominent share of the global stem cell assay market during the forecast period, led by the rise in product innovation activities and increasing focus on drug screening by biotechnology and pharmaceutical industries. Based on assay, the global stem cell assay market has been segregated into viability or cytotoxicity assay, cell identification assay, proliferation assay, differentiation assay, apoptosis assay, isolation & purification assay, and functional assay. Among these, the viability or cytotoxicity assay segment is anticipated to constitute key share of the global stem cell assay market during the forecast period, as cytotoxicity is an unavoidable stage during research.

In terms of application, the global stem cell assay market has been segmented into drug discovery & development, regenerative medicine & therapy development, and clinical research. The regenerative medicine & therapy development segment is anticipated to expand at a rapid pace during the forecast period due to the rise in incidence of Parkinson’s, Alzheimer’s, diabetes, and cancer diseases. This is anticipated to augment the focus on the development of new therapies and innovative drugs. Evolution of new therapies is estimated to provide new opportunities for the growth of the stem cell assay market during the forecast period.

Based in end-user, the global stem cell assay market has been segregated into government research institutes, private research institutes, and industry research. The industry research segment is projected to account for the major share of the global stem cell assay market during the forecast period. Growth in adoption of stem cell assays for drug screening process and testing is likely to drive the segment in the near future.

In terms of geography, the global stem cell assay market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global stem cell assay market during the forecast period. Governmental initiatives for stem cell based research in North America are anticipated to boost the stem cell assay market in the region. The stem cell assay market in Asia Pacific is estimated to expand at a rapid pace; it is projected to overtake Europe in the near future. Development in the clinical research field and rise in patient pool are projected to augment the adoption of stem cell assay in Asia Pacific.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19364

Key players operating in the stem cell assay market are Thermo Fisher Scientific, Merck KGaA, Promega Corporation, STEMCELL Technologies Inc., Bio-Techne Corporation, GE Healthcare, Cellular Dynamics International Inc., Hemogenix, Bio-Rad Laboratories, Inc., and Cell Biolabs Inc.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Phototherapy Lamps and Units for Aesthetic Medicine Market Key Manufacturers, Development Trends And Competitive

Phototherapy is one of the most advanced and widely adopted technologies. It is also known as light therapy. It is a technique in which the skin is exposed to light sources at regular time intervals. The mechanism for phototherapy was developed in the the 1950s. Currently, it is popularly used in medicine for conditions such as neonatal jaundice; hyperbilirubinemia; and a number of skin disorders such as eczema, acne vulgaris, psoriasis, and skin cancers. The 2015 research findings by the National Health Survey (NHS) suggest that since 2000, there has been an increase in non-surgical cosmetic procedures and the use of phototherapy equipment by 147%. In this technique, the treatment of skin is performed by rays originating from an electric lamp or phototherapy unit/lamp.

Read Report Overview:

https://www.transparencymarketresearch.com/phototherapy-lamps-units-aesthetic-medicine-market.html

Phototherapy treatments can be delivered to specifically targeted skin areas (affected areas) or to the whole body. Phototherapy units are commonly used for the treatment of infants, but they are also used for the treatment of nursing and pregnant women. Recently, they are also gaining popularity for the treatment of people who lack immunity. Most phototherapy units have no or very few side effects compared to other treatments. Due to this, phototherapy lamps are popularly used in enhancing cosmetic appearance. For example, the lamps are used to reduce signs of aging such as laxity, wrinkles, liver spots, etc.. Phototherapy units and lamps also play a major role in the treatment of obesity, cellulite, and fat. In 2013-2014, Europe’s National Health Service reported that 55,000 cosmetic surgeries were performed in the U.K. alone.

The global phototherapy lamps and units for aesthetic medicine market is estimated to expand rapidly in the coming years. Some of the factors driving the phototherapy lamps and units for aesthetic medicine market are increase in the number of persons suffering from skin diseases and infections. Skin disorders or infections have a significant impact on people’s daily lives. Phototherapy treatments are effective and are widely accepted. For example, in North America, during 2014-2015, 20 million aesthetic treatments were performed. Moreover, an increase in demand for aesthetic treatments in other developing countries is expected to drive the global phototherapy lamps and units for aesthetic medicines market. Additionally, technological advancements in the field of cosmetics and a rise in demand for phototherapy units for aesthetic medicines among the elderly and youth are propelling the global phototherapy lamps and units for aesthetic medicine market. Some other factors such as low awareness and lack of hygiene in developing countries such as Brazil, India, Singapore and increase in skin diseases in Australia & New Zealand due to geographical conditions are likely to drive the phototherapy lamps and units for aesthetic medicine market. However, side effects and risks associated with the therapy and lack of reimbursement policies in developing countries are expected to hinder the phototherapy lamps and units for aesthetic medicine market.

The global phototherapy lamps and units for aesthetic medicines market can be segmented based on configuration, light source, treatment of disease, end-user, and region. Based on treatment of disease, the phototherapy lamps and units for aesthetic medicine market can be divided into treatment of vitiligo, acne vulgaris, cancer, wound healing, psoriasis, and others. In terms of configuration, the phototherapy lamps and units for aesthetic medicine market can be divided into mobile units and fixed units. Based on source, the phototherapy lamps and units for aesthetic medicine market can be classified into UV lights, LED lights, infrared lights, fluorescent lights, halogen lights, and others. In terms of end-user, the market can be categorized in to ambulatory centers, skin care and cosmetic clinics, hospitals, academic & research institutes, and home care settings.

In terms of region, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global phototherapy lamps and units for aesthetic medicine market is dominated by North America, followed by Europe. This is due to the adoption new techniques, better reimbursement policies, and an increase in the number of cosmetic & aesthetic procedures. However, the market in Asia Pacific is likely to expand at a rapid pace in the coming years, due to a rise in private and public initiatives to increase awareness about skin treatment and cosmetic procedures, rise in per capita income, and increase in health care investments.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52704

Some of the key players in the phototherapy lamps and units for aesthetic medicine market are Philips Healthcare, Medtronic Plc, Masimo Corporation, Hill Laboratories, Drägerwerk AG & Co. KGaA, and GE Healthcare.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: aniket.a@tmr.com
Website: https://www.transparencymarketresearch.com/

Cell Free Protein Expression Market Research Key Players, Industry Overview and Forecasts to 2026

Global Cell Free Protein Expression Market: Overview

The demand within the global cell free protein expression market has been rising on account of key developments in the field of biological sciences. Cell free protein expression is extensively deployed to help in the synthesis of recombinant proteins that can be further used up for several bio-molecular processes. Cell free Protein expression involves the extraction of cell components to subsequently deploy biomolecular machinery for protein expression. The use of traditional methods for protein expression is gradually moving out of the wider picture in recent times due to the advent of cell-free protein expression methods. Furthermore, in-vivo methods are less effective as against the use of cell lysates, and this is a major driver of demand within the global cell free protein expression market. Several species of cell lysates may be used for cell free protein synthesis, and this further establishes the relevance of cell free protein expression.

Read Report Overview:

https://www.transparencymarketresearch.com/cell-free-protein-expression-market.html

The global cell free protein expression market may be segmented based on the following criteria: produce type, application, and region. It is integral to delve into the specifics of the aforementioned segments in order to have a better understanding of the global market.

A report on the global cell free protein expression market predicts that the market has been expanding on account of several key factors such as growth of biological experiments, need for better protein expression in microbiology, and effectiveness of lysates in protein expression. The report provides a point of reference to estimate the growth prospects of the global market in recent times. Furthermore, the key trends and opportunities floating in the global cell-free protein expression have also been elucidated in the report.

Global Cell Free Protein Expression Market: Trends and Opportunities

The supremacy of cell free protein expression over traditional method is amongst the key reasons behind the growth of the global cell free protein expression market. A number of pharmaceutical companies have initiated research in the domain of protein expression, and this has given an impetus to the global market. Biotechnological companies have also come up with several initiatives that require extensive deployment of cell-free protein expression which has created a regular inflow of demand within the global market. Moreover, the biological sector has been focusing on inducting agile and swift methods for protein synthesis. This has further enhanced the growth dynamics of the global market for cell-free protein synthesis in recent times. However, several factors such as short reaction scale of cell-free protein synthesis and the high costs associated with it are hampering the growth of the global market for cell-free protein synthesis. Moreover, the protein production is far lower in cell-free synthesis as against the amount of protein produced through traditional methods.

Global Cell Free-Protein Expression Market: Regional Dynamics

The demand within the market for cell free protein synthesis in North America has been rising at a robust rate on account of the immaculacy of the biological sciences industry in the US and Canada. Furthermore, the market for cell-free protein synthesis in Europe is also expected to flourish due to the advent of several new research centers and laboratories across England, Germany, and France.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19595

Global Cell Free Protein Expression Market: Competitive Landscape

Some of the key players in the global cell free protein expression market are GeneCopoeia, Inc., Takara Bio, Inc., Thermo Fisher Scientific, New England Biolabs, CellFree Sciences Co., Ltd., Promega Corporation, biotechrabbit GmbH, Cube Biotech GmbH, Bioneer Corporation, Jena and Bioscience GmbH.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Medical Marijuana Market Will Generate New Growth Opportunities By 2025

Cannabis sativa, Cannabis indica, and Cannabis ruderalis are referred as cannabis or marijuana and used for medicinal, recreational, and ritualistic purposes. According to the United Nations Convention on Narcotic Drugs, 1961, cannabis can be defined as the fruiting or flowering tops of the cannabis plant from which the resin has not been extracted. The term medical marijuana refers to the basic extracts or whole unprocessed marijuana plant, which is used to treat certain illness or conditions. However, the marijuana plant has not been approved or recognized as medicinal by the Food and Drug Administration (FDA) due to the lack of efficient large-scale efficient clinical trials. However, studies on chemicals in cannabis or marijuana known as cannabinoids has led to availability of two FDA-approved medication pills containing this chemical or extract. Cannabis plant contains about 104 different cannabinoids and around 750 different chemicals. THC (delta-9-tetrahydrocannabinol), CBD (cannabidiol), and CBN (cannabinol), are the primary cannabinoids in the plant.

Read Report Overview:

https://www.transparencymarketresearch.com/medical-marijuana-market.html

The global medical marijuana market holds an immense potential and is anticipated to grow at a significant CAGR during the forecast period. Continuous research and development to provide efficient therapeutic intervention for a host of diseases and symptoms is projected to boost the growth of the medical marijuana market. Several chemicals or extracts obtained from marijuana are in clinical phase. Marijuana testing is another major factor expected to propel the medical marijuana market in the near future. Rise in the number of countries approving the use of the product for therapeutic application such as pain management in cancer and HIV/AIDS patients, appetite stimulant, and decreasing nausea is projected to drive the global medical marijuana market. Rising recreational and personal use of marijuana and stringent regulatory laws are expected to restrain the market during the forecast period.

The global medical marijuana market can be segmented based on application, end-user, and region. In terms of application, the global medical marijuana market can be categorized into oncology, arthritis, chronic pain, neurology, and others. Rising chronic pain disorders is expected to fuel the growth of the market during the forecast period. Based on end-user, the market can be divided into hospitals, research and academic institutes, and others.

Geographically, the global medical marijuana market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global medical marijuana market in terms of revenue. Legalization of cannabis for medicinal and recreational use in the region and approval of the drugs for therapeutic application are fuelling the growth of the medicinal marijuana market in North America. Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Growth of the market in the region is attributed to increasing approval of medical marijuana and high R&D investment in cancer research.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30614

Key players operating in the global medical marijuana market are Pfizer, Inc., Teva Pharmaceuticals USA, Inc., Novartis International AG, Canopy Growth Corporation, Inc., CannaGrow Holdings, Inc., AbbVie, Inc, GW Pharmaceuticals, plc., and Insys Therapeutics, Inc., among others.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: aniket.a@tmr.com

Website: https://www.transparencymarketresearch.com/

Page 1 of 17

Powered by WordPress & Theme by Anders Norén